GlassScriptPhysician profile
Matthew Needleman
NPI 1972583409
$7,494.18
in general payments reported to CMS, 2019-2025
9 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,210 · 2020: $356 · 2021: $26.82 · 2022: $1,690 · 2023: $2,700 · 2024: $1,354 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,589 · Food and Beverage: $1,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,588.71 |
| Food and Beverage | $1,621.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,122.64 | 2019-2023 | Amplatzer Amulet, Aveir |
| Medtronic, INC. | $1,999.58 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $719.41 | 2019-2020 | |
| Biosense Webster, INC. | $239.73 | 2019-2025 | Carto 3 |
| Cardiva Medical, INC. | $183.08 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Optowire, Cardiva Vascade 5f Vcs |
| Bardy Diagnostics, INC. | $131.63 | 2019-2020 | |
| Acutus Medical, INC. | $52.18 | 2020 | |
| Boston Scientific Corporation | $30.58 | 2019 | |
| Stryker Corporation | $15.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Needleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.